|
시장보고서
상품코드
2055277
천골신경 조절 시장 : 제품 유형별, 용도별, 최종사용자별, 환자 연령층별, 기술별, 지역별Sacral Neuromodulation Market, By Product Type, By Application, By End User, By Patient Age Group, By Technology, By Geography |
||||||
천골신경 조절 시장은 2026년 21억 3,000만 달러로 추정되며, 2033년까지 46억 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 11.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 21억 3,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 11.60% | 2033년 시장 규모 예측 : | 46억 달러 |
세계 천골신경 조절 시장은 광범위한 신경 조절 산업 내의 전문 분야로, 천골신경을 표적으로 한 전기 자극을 통해 다양한 골반저 장애를 치료하도록 설계된 혁신적인 의료기기에 중점을 두고 있습니다. 천골신경 조절술(천골신경 자극 요법: SNS라고도 함)은 과활동성 방광, 요폐, 대변 실금, 만성 골반통 증후군 등의 심각한 증상을 치료하는 저침습적 치료법으로 등장했습니다. 이 첨단 의료 기술은 천골신경에 제어된 전기 펄스를 전달하는 소형 장치를 이식하여, 방광, 장 및 골반저의 기능을 관장하는 신경 경로를 효과적으로 조절합니다.
이 시장에는 내장형 펄스 발생기, 리드선, 외부 자극 장치 및 관련 수술 기구 등 다양한 구성 요소가 포함됩니다. 골반저 장애에 대한 인식 제고, 고령화 심화, 그리고 최소 침습 수술에 대한 수용 확대에 힘입어 천골신경 조절 시장은 눈부신 성장세를 보이고 있습니다. 의료 종사자들은 만성 골반 질환과 관련된 장기적인 의료비를 절감하면서도 환자의 삶의 질을 크게 향상시키는 비용 대비 효과가 높은 치료 옵션으로서 SNS를 점점 더 인식하고 있습니다. 시장 확대는 치료 효과와 환자의 편의성을 높이는 충전식 기기, MRI 호환 시스템, 그리고 프로그래밍 기능의 향상 등 지속적인 기술 발전에 힘입어 더욱 가속화되고 있습니다.
시장 역학
세계 천골신경 조절 시장은 전반적인 견실한 성장세를 뒷받침하는 몇 가지 강력한 촉진요인에 힘입어 성장하고 있습니다. 주요 원인은 골반저 기능 장애의 유병률 증가에 기인하며, 특히 전 세계적으로 고령화 사회가 진행됨에 따라 과활동성 방광이나 대변 실금과 같은 증상이 노화와 함께 증가하고 있습니다. 기존의 외과적 시술에 대한 대체 수단으로서 천골신경 조절의 유효성에 대한 의료진과 환자의 인식이 높아지면서, 시장 확대에 크게 기여하고 있습니다. 충전식 이식형 펄스 발생 장치, MRI 호환 기기, 첨단 프로그래밍 시스템 등의 기술적 진보는 치료 성과를 향상시키고 대상 환자층을 확대되고 있습니다.
그러나 시장에는 성장 가능성을 제한할 수 있는 뚜렷한 제약 요인이 존재합니다. 장비의 높은 비용과 관련 수술 비용은 특히 비용에 민감한 의료 제도나 보험 적용 범위가 제한적인 개발도상국에서 도입의 큰 걸림돌이 되고 있습니다. 환자 선정 기준의 복잡성과 의료 종사자에 대한 전문적인 교육의 필요성은 특정 지역에서 시장 침투를 제한할 수 있습니다. 게다가 감염 위험이나 기기 고장 등 기기 이식에 수반되는 잠재적인 합병증은 환자와 의사 모두 이 치료법을 채택하는 것을 주저하게 만들 수 있습니다. 이러한 과제가 있음에도 불구하고, 만성 골반통, 간질성 방광염, 신경성 방광 질환과 같은 기존의 적응증을 넘어 천골신경 조절 기술의 적용 범위가 확대됨에 따라 큰 성장 기회가 생겨나고 있습니다. 신흥 시장의 의료 인프라 구축이 진전되고, 의료비 증가 및 보상 정책 개선과 맞물려, 지리적 확장을 목표로 하는 시장 참여자들에게 큰 성장 기회가 열리고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 천골신경 조절 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 천골신경 조절 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업 및 금융 애널리스트를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 천골신경 조절 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 수행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 천골신경 조절 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 천골신경 조절 시장 : 용도별, 2021년-2033년
제6장 세계의 천골신경 조절 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 천골신경 조절 시장 : 환자 연령층별, 2021년-2033년
제8장 세계의 천골신경 조절 시장 : 기술별, 2021년-2033년
제9장 세계의 천골신경 조절 시장 : 지역별, 2021년-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
LSH 26.06.23Sacral Neuromodulation Market is estimated to be valued at USD 2.13 Bn in 2026 and is expected to reach USD 4.60 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.13 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.60% | 2033 Value Projection: | USD 4.60 Bn |
The global sacral neuromodulation market represents a specialized segment within the broader neuromodulation industry, focusing on innovative medical devices designed to treat various pelvic floor disorders through targeted electrical stimulation of sacral nerves. Sacral neuromodulation, also known as sacral nerve stimulation (SNS), has emerged as a minimally invasive therapeutic approach that addresses debilitating conditions including overactive bladder, urinary retention, fecal incontinence, and chronic pelvic pain syndromes. This advanced medical technology involves the implantation of small devices that deliver controlled electrical pulses to the sacral nerves, effectively modulating neural pathways responsible for bladder, bowel, and pelvic floor function.
The market encompasses various components including implantable pulse generators, leads, external stimulators, and associated surgical instruments. With growing awareness of pelvic floor disorders, aging demographics, and increasing acceptance of minimally invasive procedures, the sacral neuromodulation market has witnessed substantial growth trajectory. Healthcare providers increasingly recognize SNS as a cost-effective treatment option that significantly improves patients' quality of life while reducing long-term healthcare costs associated with chronic pelvic conditions. The market's expansion is further supported by ongoing technological advancements, including rechargeable devices, MRI-compatible systems, and improved programming capabilities that enhance treatment efficacy and patient comfort.
Market Dynamics
The global sacral neuromodulation market is propelled by several compelling drivers that collectively fuel its robust growth trajectory. The primary driver stems from the increasing prevalence of pelvic floor disorders, particularly among aging populations worldwide, where conditions like overactive bladder and fecal incontinence become more common with advancing age. Rising awareness among healthcare professionals and patients regarding the efficacy of sacral neuromodulation as a minimally invasive alternative to traditional surgical interventions significantly contributes to market expansion. Technological advancements, including the development of rechargeable implantable pulse generators, MRI-compatible devices, and sophisticated programming systems, enhance treatment outcomes and broaden the addressable patient population.
However, the market faces notable restraints that could potentially limit its growth potential. High device costs and associated surgical expenses create significant barriers to adoption, particularly in cost-sensitive healthcare systems and developing regions with limited reimbursement coverage. The complexity of patient selection criteria and the requirement for specialized training among healthcare providers can restrict market penetration in certain geographical areas. Additionally, potential complications associated with device implantation, including infection risks and device malfunction, may deter both patients and physicians from adopting this therapy. Despite these challenges, substantial opportunities emerge from expanding applications of sacral neuromodulation technology beyond traditional indications, including chronic pelvic pain, interstitial cystitis, and neurogenic bladder conditions. Growing healthcare infrastructure in emerging markets, coupled with increasing healthcare expenditure and improving reimbursement policies, presents significant growth opportunities for market players seeking geographical expansion.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global sacral neuromodulation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic"¯plc, Boston Scientific Corporation, Abbott Laboratories, Axonics"¯Inc, Nevro"¯Corp, LivaNova"¯PLC, NeuroPace"¯Inc, Synapse"¯Biomedical"¯Inc, Beijing"¯PINS"¯Medical"¯Co.,"¯Ltd, Saluda"¯Medical"¯Pty"¯Ltd, Nuvectra"¯Corp, Johnson"¯and"¯Johnson, Valencia"¯Technologies, EBT"¯Medical, and Inspire"¯Medical"¯Systems.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global sacral neuromodulation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sacral neuromodulation market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Implantable Pulse Generators (IPGs)
- Lead Electrodes
- External/Non"'Implantable Pulse Generators (EPGs)
- Accessories and System Components
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Urinary Incontinence (stress, urge, mixed)
- Overactive Bladder (OAB)
- Fecal Incontinence
- Urinary Retention
- Chronic Pelvic Pain and Related Pelvic Floor Disorders
- Others (e.g., gastrointestinal motility disorders, pediatric indications)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Large Medical Centres
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics (Urology/Gastroenterology/Pelvic"¯Health)
- Research and Academic Institutes
- Patient Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Rechargeable Systems
- Non"'Rechargeable Systems
- Wired/Lead Systems vs Wireless/Leadless Systems
- Trial Systems (temporary leads) vs Permanent Systems
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic"¯plc
- Boston Scientific Corporation
- Abbott Laboratories
- Axonics"¯Inc
- Nevro"¯Corp
- LivaNova"¯PLC
- NeuroPace"¯Inc
- Synapse"¯Biomedical"¯Inc
- Beijing"¯PINS"¯Medical"¯Co.,"¯Ltd
- Saluda"¯Medical"¯Pty"¯Ltd
- Nuvectra"¯Corp
- Johnson"¯and"¯Johnson
- Valencia"¯Technologies
- EBT"¯Medical
- Inspire"¯Medical"¯Systems
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Sacral Neuromodulation Market, By Product Type
- Global Sacral Neuromodulation Market, By Application
- Global Sacral Neuromodulation Market, By End User
- Global Sacral Neuromodulation Market, By Patient Age Group
- Global Sacral Neuromodulation Market, By Technology
- Global Sacral Neuromodulation Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Sacral Neuromodulation Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Implantable Pulse Generators (IPGs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lead Electrodes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- External/Non"'Implantable Pulse Generators (EPGs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Accessories and System Components
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Sacral Neuromodulation Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Urinary Incontinence (stress, urge, mixed)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Overactive Bladder (OAB)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fecal Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Urinary Retention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic Pelvic Pain and Related Pelvic Floor Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (e.g., gastrointestinal motility disorders, pediatric indications)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Sacral Neuromodulation Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Large Medical Centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics (Urology/Gastroenterology/Pelvic"¯Health)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Sacral Neuromodulation Market, By Patient Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Sacral Neuromodulation Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Rechargeable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Non"'Rechargeable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Wired/Lead Systems vs Wireless/Leadless Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Trial Systems (temporary leads) vs Permanent Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Sacral Neuromodulation Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Medtronic"¯plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Axonics"¯Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nevro"¯Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova"¯PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NeuroPace"¯Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Synapse"¯Biomedical"¯Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Beijing"¯PINS"¯Medical"¯Co.,"¯Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Saluda"¯Medical"¯Pty"¯Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nuvectra"¯Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson"¯and"¯Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Valencia"¯Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EBT"¯Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Inspire"¯Medical"¯Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
